Supported by Non-Covid-19 Income Growth, DGNS Still Consistently Books Profits.

TRIBUNNEWS.COM, JAKARTA – Pharmaceutical issuer PT Diagnos Laboratorium Utama Tbk. (DGNS) recorded a profit of IDR 8.4 billion in the first quarter of 2022, up sharply from the previous achievement of below IDR 1 billion in the fourth quarter of 2021.

This increase in profit shows the company's consistency in maintaining loose growth during the pandemic. The increase in cash and cash equivalents, amounting to IDR 9.1 billion qoq to IDR 53.8 billion will be DGNS's main weapon in its business development in 2022.

In addition to being supported by massive outlet growth reaching 36 outlets in 2022, DGNS also recorded non-Covid-19 testing source revenues increased by IDR 11 billion or 57.8 percent Yoy to IDR 30 billion in the first quarter of 2022 from the previous IDR 19 billion in the first quarter of 2021.

This was supported by the number of non-covid tests which increased by 41.3 percent Yoy from the previous 121 thousand tests to 171 thousand tests. The growth of non-covid testing will be the main pillar of DGNS growth in the era after the covid-19 pandemic.

DGNS in addition to focusing on the growth of outlets and building a clinical laboratory ecosystem with a network of hospitals and clinics, DGNS also continues to innovate in providing the best test services for its customers, where DGNS's Medical Checkup service also recorded a growth of 259.8 percent yoy to 2,853 examinations from the previous only 779 examinations.

DGNS Corporate Secretary Fanfan Riksani said, in 2022 DGNS will build a master lab to become a center for clinical laboratory examination services as an answer to the needs of health services needed by the community.

He added, in addition to the parent lab, DGNS's parent company, PT Bundamedik Tbk (BMHS) together with PT Morulla Indonesia continue to grow the number of hospitals, clinics which will contribute positively to DGNS's revenue in the future.

Source : https://www.tribunnews.com/bisnis/2022/05/18/ditopang-pertumbuhan-pendapatan-non-covid-19-dgns-masih-konsisten-bukukan-laba